OneSource Specialty Pharma Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹449.02 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.86 per cent from ₹428.22 crore. This corresponds to a year-on-year *(YoY) growth of 37.20 per cent.
Operating Profit
Operating Profit stands at ₹119.04 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.50 per cent from ₹91.92 crore. This corresponds to a year-on-year *(YoY) growth of 39.05 per cent.
PBDT
PBDT stands at ₹92.05 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.67 per cent from ₹71.54 crore. This corresponds to a year-on-year *(YoY) growth of 45.19 per cent.
Profit Before Tax
Profit Before Tax stands at ₹20.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7,100.00 per cent from ₹-0.29 crore. This corresponds to a year-on-year *(YoY) growth of 561.36 per cent.
Net Profit
Net Profit stands at ₹25.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 443.48 per cent from ₹4.60 crore. This represents a 13,257.89 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
OneSource Specialty Pharma Ltd News
OneSource Specialty Pharma Ltd Earnings
- YOY
- QOQ
OneSource Specialty Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
OneSource Specialty Pharma Ltd Research Reports
OneSource Specialty Pharma Ltd Financial Reports
OneSource Specialty Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| OneSource Speci. | 13.66% | 17.68% | 1.51% | -7.95% | -9.78% | -12.38% |
| Rubicon Research | 1.78% | 4.62% | -4.52% | -1.09% | 59.09% | 145.38% |
| Neuland Labs. | 1.05% | 1.73% | -9.95% | 2.34% | 33.62% | 22.61% |
| Granules India | 1.48% | 3.59% | -2.03% | -1.63% | 18.00% | 46.07% |
| Cohance Life | 2.89% | 3.74% | 5.01% | 11.89% | -3.54% | -44.22% |
| Caplin Point Lab | 2.92% | 5.58% | -17.79% | -9.43% | 35.40% | 16.45% |
| Shilpa Medicare | 0.59% | 7.73% | -11.03% | 50.39% | 123.09% | 152.58% |
Company Info
Company Information
Chairman & Non Executive Dir. : Arun Kumar
Managing Director & CEO : Neeraj Sharma
Independent Non Exe. Director : Debarati Sen
Independent Non Exe. Director : Claudio Albrecht
Independent Non Exe. Director : Rashmi Harshadrai Barbhaiya
Independent Non Exe. Director : Vijay Paul Karwal
Independent Non Exe. Director : Colin Michael Bond
Non Executive Director : Bharat Shah
Company Sec. & Compli. Officer : Trisha A